Skip to main content

BioCommerce Week s Index to the Diversified Molecular Biology Tools Companies: Sep 30, 2004


BCW Index Takes its First Dip, Falls 8 Percent

After three weeks of gains, the BioCommerce Week Index of Diversified Molecular Biology Tool Companies finished down this week, finishing at $31.25 Tuesday, down 3 percent from last week’s $32.19 close.

The fall is in step with broader market measures. The Dow, the S&P 500, and Nasdaq — as well as the Nasdaq biotech — all finished down, between 1 and 2 percent lower than last week.

Of the 15 companies in the BCW Index, 12 saw their share prices fall during the week. Agilent led this group, falling to $21.29 from $23.32, an 8 percent drop, while shares of Molecular Devices, Waters, PerkinElmer, and Invitrogen fell more than 5 percent during a week when many of the BCW Index company executives were in New York to present at the annual UBS Global Life Sciences Conference.

Beckman Coulter and Applied Biosystems recorded fractions-of-a-percentage gains while Harvard Bio ended even at $4.45.

Agilent’sdrop comes after making gains of 14 percent over the previous weeks since the Index was first published on Sept. 8.

PerkinElmer, even with a 5.38-percent dip this week, still is above its index-opening price of $18.71, while Applied Bio dips below its index opening price of $18.81.

After gaining nearly 20 percent from the start of the index, Invitrogen stands at $55.38, after starting at $48.87.

The index is a weekly compilation of stock prices of a select group of public molecular biology tools companies with multiple platform technologies, and business units with executives dedicated to integrated biology efforts, or with investments in this emerging field.

— Mo Krochmal ([email protected])

File Attachments
The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.